The @ParentProjectMD Annual Conference is just around the corner, and we'll be there. Find us in Orlando June 25–27, catch the Satellos presentation, and stop by our booth to say hello. #PPMD2026 #Duchenne #DMD $MSLE $MSCL.TO

Muscle is remarkable. It repairs itself constantly, responding to the demands we place on it every day. In Duchenne muscular dystrophy, that repair process breaks down, and muscles can't keep up with the damage. Satellos is working to change that, with a therapy designed to reset the muscle’s own ability to rebuild. Learn how at satellos.com/science #MuscleRegeneration #Duchenne $MSLE $MSCL.TO

Great discussions underway at the @Oppenheimer CNS & Neuro-Muscular Summit. Proud to have our CEO, Frank Gleeson, join fellow industry leaders to discuss next-generation therapeutics in genetic muscle disorders. #OppenheimerSummit #NeuromuscularDisease #Duchenne $MSLE $MSCL.TO

We’re looking forward to participating in the @Jefferies Global Healthcare Conference in New York and the @Oppenheimer CNS & Neuro-Muscular Summit in Miami this June. More details here: ir.satellos.com/news/news-de… $MSLE $MSCL.TO

A few moments from @cureduchenne FUTURES 2026 last week.💙 Thank you to everyone who stopped by our booth, joined our presentation, and shared in the important conversations happening across the #Duchenne community. We’re grateful for the opportunity to connect, learn, and continue advancing the future of #muscleregeneration together. #FUTURES2026 $MSLE $MSCL.TO

Last week, the Satellos team came together for our all-company meeting alongside members of our Board of Directors. It was a valuable opportunity to reflect on our progress, align on what’s ahead, and spend time together in person. Grateful for the people across our organization who continue to push the science forward with purpose, collaboration, and momentum. Excited for what’s next. #MuscleRegeneration #Duchenne $MSLE $MSCL.TO

We’re heading to @CureDuchenne FUTURES 2026 in Orlando.💙 Satellos will be presenting and exhibiting at this year’s conference, and we’re looking forward to connecting with the #Duchenne community, partners, and advocates driving progress forward. If you’re attending, stop by our booth — we’d love to meet you. #FUTURES2026 #MuscleRegeneration $MSLE $MSCL.TO

Satellos reported today its first quarter financial results and recent company progress. Full details here: ir.satellos.com/news/news-de… $MSLE $MSCL

At Satellos, we’re often focused on what’s right in front of us, including data, timelines, and next steps. At the Team Joseph #StrongerTogether meeting in Detroit, we took a moment to look further ahead. One of the sessions asked us to imagine a newspaper front page 10 years from now, capturing the big stories we hope to see for those living with #Duchenne muscular dystrophy. It was a simple exercise, but a meaningful one that connected today’s work to what it could ultimately mean. Sharing a few moments from the meeting here, including that activity, and yes, that artwork is ours. Thank you to Team Joseph for bringing the community together in such a thoughtful and impactful way. $MSLE $MSCL

We’ll be in Detroit April 28–30, for the Team Joseph #StrongerTogether event. It’s a chance to come together with the community, share perspectives, and move toward better outcomes for people living with #Duchenne. We’re looking forward to the conversations ahead. $MSLE $MSCL

Satellos is pleased to have our CEO, Frank Gleeson, speaking at #MaRSImpactHealth on April 23 in Toronto. He’ll share our progress in advancing muscle regeneration and the potential to change the treatment landscape for people living with #Duchenne. Hope to see you there: impacthealth.marsdd.com/?utm… #MuscleRegeneration $MSLE $MSCL

Join us in Toronto for the Bloom Burton & Co. Healthcare Investor Conference, April 21–22. CEO Frank Gleeson (@frank_satellos) will present on April 21 at a.m. ET. He and CFO Liz Williams (@CdnBioCFO) will be available for investor meetings during the conference. Learn more: ir.satellos.com/news/news-de… $MSLE $MSCL

Duchenne is typically viewed through the lens of muscle damage. An equally important question is: What happens to the body’s ability to repair that damage? This video outlines the biological framework behind our approach. #MuscleRegeneration #Duchenne $MSLE $MSCL

Thank you, Steven, for the insightful discussion with our CEO, Frank Gleeson. We appreciate the opportunity to highlight our regenerative approach and the meaningful progress we’re making in bringing SAT-3247 to people living with #Duchenne and other degenerative conditions. $MSLE $MSCL

$MSLE today announced full-year 2025 financial results and corporate highlights. Full details here: ir.satellos.com/news/news-de… $MSCL